Terms: = Leukemia AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Prognosis
43 results:
1. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid leukemia.
Jin P; Wang X; Jin Q; Zhang Y; Shen J; Jiang G; Zhu H; Zhao M; Wang D; Li Z; Zhou Y; Li W; Zhang W; Liu Y; Wang S; Jin W; Cao Y; Sheng G; Dong F; Wu S; Li X; Jin Z; He M; Liu X; Chen L; Zhang Y; Wang K; Li J
Cancer Res; 2024 May; 84(10):1583-1596. PubMed ID: 38417135
[TBL] [Abstract] [Full Text] [Related]
2. The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation.
Sun L; Wang W; Han C; Huang W; Sun Y; Fang K; Zeng Z; Yang Q; Pan Q; Chen T; Luo X; Chen Y
Mol Cell; 2021 Nov; 81(21):4493-4508.e9. PubMed ID: 34555354
[TBL] [Abstract] [Full Text] [Related]
3. Small-Molecule Inhibitors Targeting eif4a in leukemia.
Jia X; Zhou H
Curr Protein Pept Sci; 2021; 22(7):559-566. PubMed ID: 34042032
[TBL] [Abstract] [Full Text] [Related]
4. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
[TBL] [Abstract] [Full Text] [Related]
5. Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic leukemia/Small Lymphocytic Lymphoma.
Ammann EM; Shanafelt TD; Larson MC; Wright KB; McDowell BD; Link BK; Chrischilles EA
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e11-e25. PubMed ID: 28802891
[TBL] [Abstract] [Full Text] [Related]
6. [Role of eukaryotic translation initiation factor 4G in tumor].
Zhang S; Huang N; Pan X; Zang JL; Guan XX; Zhang JH; Liu LC; Lei XY
Sheng Li Xue Bao; 2016 Apr; 68(2):207-14. PubMed ID: 27108909
[TBL] [Abstract] [Full Text] [Related]
7. A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.
Horvilleur E; Sbarrato T; Hill K; Spriggs RV; Screen M; Goodrem PJ; Sawicka K; Chaplin LC; Touriol C; Packham G; Potter KN; Dirnhofer S; Tzankov A; Dyer MJ; Bushell M; MacFarlane M; Willis AE
Leukemia; 2014 May; 28(5):1092-102. PubMed ID: 24135829
[TBL] [Abstract] [Full Text] [Related]
8. Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
Moroz V; Machin D; Faldum A; Hero B; Iehara T; Mosseri V; Ladenstein R; De Bernardi B; Rubie H; Berthold F; Matthay KK; Monclair T; Ambros PF; Pearson AD; Cohn SL; London WB
Eur J Cancer; 2011 Mar; 47(4):561-71. PubMed ID: 21112770
[TBL] [Abstract] [Full Text] [Related]
9. Long-term study of indolent adult T-cell leukemia-lymphoma.
Takasaki Y; Iwanaga M; Imaizumi Y; Tawara M; Joh T; Kohno T; Yamada Y; Kamihira S; Ikeda S; Miyazaki Y; Tomonaga M; Tsukasaki K
Blood; 2010 Jun; 115(22):4337-43. PubMed ID: 20348391
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathologic study of 15 splenectomy specimens of patients with hairy cell leukemia].
Li ZQ; Chen HS; Liu EB; Sun Q; Fang LH; Sun FJ; Zhang PH; Yang QY; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):769-73. PubMed ID: 20079018
[TBL] [Abstract] [Full Text] [Related]
11. Time trends and prognostic factors for survival from childhood cancer: a report from the Childhood Cancer Registry of Piedmont (Italy).
Dama E; Pastore G; Mosso ML; Maule MM; Zuccolo L; Magnani C; Merletti F
Eur J Pediatr; 2006 Apr; 165(4):240-9. PubMed ID: 16411094
[TBL] [Abstract] [Full Text] [Related]
12. Coexistence of pregnancy and cancer.
Jacobs IA; Chang CK; Salti GI
Am Surg; 2004 Nov; 70(11):1025-9. PubMed ID: 15586520
[TBL] [Abstract] [Full Text] [Related]
13. Very long survival in pediatric cancer between 1944 and 1993.
Zhao G; Boysen CD; Brown EF; Hassanein KM; Holmes FF; Holmes GE
Chin Med J (Engl); 1999 Jul; 112(7):615-9. PubMed ID: 11601255
[TBL] [Abstract] [Full Text] [Related]
14. Second malignancies after Hodgkin's disease: the Munich experience.
Munker R; Grützner S; Hiller E; Aydemir U; Enne W; Dietzfelbinger H; Busch M; Haas R; Emmerich B; Schmidt M; Dühmke E; Hölzel D; Wilmanns W
Ann Hematol; 1999 Dec; 78(12):544-54. PubMed ID: 10647878
[TBL] [Abstract] [Full Text] [Related]
15. Acute promyelocytic leukaemia: a retrospective analysis of patients treated at St. Bartholomew's Hospital 1969-1995.
Slater S; Carter M; Howe K; Amess J; Rohatiner AZ; Lister TA
Ann Hematol; 1999 Mar; 78(3):131-7. PubMed ID: 10211755
[TBL] [Abstract] [Full Text] [Related]
16. Acute lymphoblastic leukemia with severe skeletal involvement: a subset of childhood leukemia with a good prognosis.
Müller HL; Horwitz AE; Kühl J
Pediatr Hematol Oncol; 1998; 15(2):121-33. PubMed ID: 9592839
[TBL] [Abstract] [Full Text] [Related]
17. The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen-year period.
Davis CL; Rohatiner AZ; Lim J; Whelan JS; Oza AM; Amess J; Love S; Stead E; Lister TA
Br J Haematol; 1993 Mar; 83(3):404-11. PubMed ID: 7683485
[TBL] [Abstract] [Full Text] [Related]
18. [Acute lymphoblastic leukemias off therapy: course of 80 cases after treatment cessation].
Sánchez Fayos J; Bernacer M; Olavarría E; Outeiriño J; Prieto E; Román A; Pacho E; Villalobos E; Pérez A; Myric A
Sangre (Barc); 1992 Dec; 37(6):439-47. PubMed ID: 1293795
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical approach to infection in patients with hematologic malignancy].
Funada H
Gan To Kagaku Ryoho; 1992 Feb; 19(2):178-83. PubMed ID: 1371045
[TBL] [Abstract] [Full Text] [Related]
20. Response to salvage therapy and survival after relapse in acute myelogenous leukemia.
Keating MJ; Kantarjian H; Smith TL; Estey E; Walters R; Andersson B; Beran M; McCredie KB; Freireich EJ
J Clin Oncol; 1989 Aug; 7(8):1071-80. PubMed ID: 2666590
[TBL] [Abstract] [Full Text] [Related]
[Next]
